Credit Suisse analyst Andrew Kuske downgrades Boralex (TSX:BLX) from Outperform to Neutral.
Novo Nordisk Shares Fall After Q2 Earnings Despite Raised Annual Outlook
Novo Nordisk A/S (NYSE:NVO) reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis). Operating profit…
